Anabelle Wong: Role: ConceptualizationRole: Data curationRole: Formal analysisRole: InvestigationRole:
MethodologyRole: ValidationRole: VisualizationRole: Writing – original draftRole:
Writing – review & editing
Laura Andrea Barrero Guevara: Role: ConceptualizationRole: Data curationRole: Formal analysisRole: InvestigationRole:
MethodologyRole: SoftwareRole: VisualizationRole: Writing – original draftRole: Writing
– review & editing
Elizabeth Goult: Role: ConceptualizationRole: Formal analysisRole: InvestigationRole: MethodologyRole:
SoftwareRole: VisualizationRole: Writing – original draftRole: Writing – review &
editing
Michael Briga: Role: Data curationRole: Formal analysisRole: InvestigationRole: MethodologyRole:
Project administrationRole: Writing – review & editing
Sarah C. Kramer: Role: ConceptualizationRole: InvestigationRole: Writing – review & editing
Aleksandra Kovacevic: Role: ConceptualizationRole: Formal analysisRole: InvestigationRole: MethodologyRole:
SoftwareRole: Writing – review & editing
Lulla Opatowski: Role: ConceptualizationRole: MethodologyRole: ResourcesRole: SupervisionRole: Writing
– review & editing
Matthieu Domenech de Cellès:
ORCID: https://orcid.org/0000-0002-9302-4858
Role: ConceptualizationRole: Funding acquisitionRole: MethodologyRole: Project administrationRole:
SupervisionRole: Writing – original draftRole: Writing – review & editing
Tom C. Hobman: Role: Editor
Journal ID (nlm-ta): PLoS Pathog
Journal ID (iso-abbrev): PLoS Pathog
Journal ID (publisher-id): plos
Title:
PLOS Pathogens
Publisher:
Public Library of Science
(San Francisco, CA USA
)
ISSN
(Print):
1553-7366
ISSN
(Electronic):
1553-7374
Publication date
(Electronic):
8
March
2023
Publication date Collection:
March
2023
Volume: 19
Issue: 3
Electronic Location Identifier: e1011167
Affiliations
[1
]
Infectious Disease Epidemiology group, Max Planck Institute for Infection Biology,
Berlin, Germany
[2
]
Institute of Public Health, Charité–Universitätsmedizin Berlin, Berlin, Germany
[3
]
Epidemiology and Modelling of Antibiotic Evasion, Institut Pasteur, Université Paris
Cité, Paris, France
[4
]
Anti-infective Evasion and Pharmacoepidemiology Team, CESP, Université Paris-Saclay,
Université de Versailles Saint-Quentin-en-Yvelines, INSERM U1018 Montigny-le-Bretonneux,
France
University of Alberta, CANADA
Author notes
MDdC received postdoctoral funding (2017–2019) from Pfizer and consulting fees from
GSK. LO reports research grants from Pfizer and Sanofi-Pasteur through her institution.
All other authors declare no competing interests.
Author information
Article
Publisher ID:
PPATHOGENS-D-22-00862
DOI: 10.1371/journal.ppat.1011167
PMC ID: 9994710
PubMed ID: 36888684
SO-VID: c3f27a08-c5ae-4503-ba1f-ebfab3510b41
Copyright © © 2023 Wong et al
License:
This is an open access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided
the original author and source are credited.
We did not receive specific funding for this study.
Subject:
Review
Subject:
Biology and life sciences
Subject:
Organisms
Subject:
Viruses
Subject:
RNA viruses
Subject:
Coronaviruses
Subject:
SARS coronavirus
Subject:
SARS CoV 2
Subject:
Biology and life sciences
Subject:
Microbiology
Subject:
Medical microbiology
Subject:
Microbial pathogens
Subject:
Viral pathogens
Subject:
Coronaviruses
Subject:
SARS coronavirus
Subject:
SARS CoV 2
Subject:
Medicine and health sciences
Subject:
Pathology and laboratory medicine
Subject:
Pathogens
Subject:
Microbial pathogens
Subject:
Viral pathogens
Subject:
Coronaviruses
Subject:
SARS coronavirus
Subject:
SARS CoV 2
Subject:
Biology and life sciences
Subject:
Organisms
Subject:
Viruses
Subject:
Viral pathogens
Subject:
Coronaviruses
Subject:
SARS coronavirus
Subject:
SARS CoV 2
Subject:
Medicine and Health Sciences
Subject:
Medical Conditions
Subject:
Infectious Diseases
Subject:
Respiratory Infections
Subject:
Medicine and Health Sciences
Subject:
Medical Conditions
Subject:
Respiratory Disorders
Subject:
Respiratory Infections
Subject:
Medicine and Health Sciences
Subject:
Pulmonology
Subject:
Respiratory Disorders
Subject:
Respiratory Infections
Subject:
Biology and life sciences
Subject:
Organisms
Subject:
Viruses
Subject:
RNA viruses
Subject:
Orthomyxoviruses
Subject:
Influenza viruses
Subject:
Influenza A virus
Subject:
Biology and life sciences
Subject:
Microbiology
Subject:
Medical microbiology
Subject:
Microbial pathogens
Subject:
Viral pathogens
Subject:
Orthomyxoviruses
Subject:
Influenza viruses
Subject:
Influenza A virus
Subject:
Medicine and health sciences
Subject:
Pathology and laboratory medicine
Subject:
Pathogens
Subject:
Microbial pathogens
Subject:
Viral pathogens
Subject:
Orthomyxoviruses
Subject:
Influenza viruses
Subject:
Influenza A virus
Subject:
Biology and life sciences
Subject:
Organisms
Subject:
Viruses
Subject:
Viral pathogens
Subject:
Orthomyxoviruses
Subject:
Influenza viruses
Subject:
Influenza A virus
Subject:
Medicine and Health Sciences
Subject:
Pathology and Laboratory Medicine
Subject:
Pathogens
Subject:
Medicine and Health Sciences
Subject:
Medical Conditions
Subject:
Infectious Diseases
Subject:
Co-Infections
Subject:
Medicine and Health Sciences
Subject:
Medical Conditions
Subject:
Infectious Diseases
Subject:
Viral Diseases
Subject:
Influenza
Subject:
Medicine and Health Sciences
Subject:
Medical Conditions
Subject:
Infectious Diseases
Subject:
Viral Diseases
Subject:
Covid 19
Subject:
Medicine and Health Sciences
Subject:
Epidemiology
Subject:
Infectious Disease Epidemiology
Subject:
Medicine and Health Sciences
Subject:
Medical Conditions
Subject:
Infectious Diseases
Subject:
Infectious Disease Epidemiology